(Stroke. 1996;27:2005-2011.)
© 1996 American Heart Association, Inc.
Articles |
the Departments of Neurology (R.F.M., S.F.A., M.F.) and Internal Medicine (R.B., F.P.Q., J.M.W.), University of Southern California School of Medicine, Los Angeles; and Scripps Research Institute, La Jolla, Calif (A.G., J.H.G., J.A.F.).
Correspondence to Richard F. Macko, MD, University of Maryland School of Medicine, Department of Neurology, 22 N Greene St, Baltimore, MD 21201-1595.
Background and Purpose Infection/inflammation appears to be an important predisposing risk factor for brain infarction, but little is known regarding underlying molecular mechanisms. We examined the hypothesis that patients with brain infarction preceded by infection/inflammation within 1 week could be identified by a distinctive procoagulant laboratory profile characterized by abnormalities in the protein C system and endogenous fibrinolysis.
Methods We performed a case-control study examining the relationship between preceding systemic infectious/inflammatory syndromes and selected immunohematologic variables in 36 patients with acute brain infarction and 81 control subjects (community control subjects [n=47] and hospitalized nonstroke neurological patient controls [n=34]).
Results The stroke group had a lower mean level of the circulating antithrombotic enzyme activated protein C (APC) (4.33±0.34% [log-transformed percentage of control value, mean±SD]) than community control subjects (4.51±0.27%, P<.02) or hospitalized neurological patient controls (4.57±0.31%, P<.005). The lowest circulating APC levels were found in the stroke group with antecedent infection/inflammation within 1 week preceding index brain infarction (4.23±0.4%, n=12). Within the stroke group, circulating APC levels were inversely related to IgG isotype anticardiolipin antibody titers (r=-.55, P<.001). Only the stroke group with infection/inflammation within 1 week had elevated plasma C4b binding protein compared with control subjects (141±61% versus 112±44%, P<.05). Stroke patients with antecedent infection/inflammation had a distinctively lower ratio of active tissue plasminogen activator to plasminogen activator inhibitor (0.11±0.04, n=9) than other stroke patients (0.19±0.06, n=9, P<.01) and control subjects (0.22±0.16, n=17, P<.02).
Conclusions Impairments in the protein C pathway and endogenous fibrinolysis may contribute to the increased risk for brain infarction after recent (
1 week) infection/inflammation. A decrease in the circulating anticoagulant APC may be related to elevated antiphospholipid antibody titers.
Key Words: blood coagulation blood proteins cerebral infarction fibrinolysis infection
This article has been cited by other articles:
![]() |
G. P. Van Guilder, G. L. Hoetzer, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza Metabolic syndrome and endothelial fibrinolytic capacity in obese adults Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R39 - R44. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukui, A. Abla, J. J. Teuteberg, D. M. McNamara, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Cerebrovascular accidents in patients with a ventricular assist device J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 114 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chamorro, X. Urra, and A. M. Planas Infection After Acute Ischemic Stroke: A Manifestation of Brain-Induced Immunodepression Stroke, March 1, 2007; 38(3): 1097 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Van Guilder, G. L. Hoetzer, D. T. Smith, H. M. Irmiger, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza Endothelial t-PA release is impaired in overweight and obese adults but can be improved with regular aerobic exercise Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E807 - E813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Zeller, A. Lenz, C.C. Eschenfelder, P. Zunker, and G. Deuschl Platelet-Leukocyte Interaction and Platelet Activation in Acute Stroke With and Without Preceding Infection Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1519 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Albert, C. J. Beller, J. A. Walter, B. Arnrich, U. P. Rosendahl, H. Priss, and J. Ennker Preoperative high leukocyte count: a novel risk factor for stroke after cardiac surgery Ann. Thorac. Surg., May 1, 2003; 75(5): 1550 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Paganini-Hill, E. Lozano, G. Fischberg, M. Perez Barreto, K. Rajamani, S.F. Ameriso, P.N.R. Heseltine, and M. Fisher Infection and Risk of Ischemic Stroke: Differences Among Stroke Subtypes Stroke, February 1, 2003; 34(2): 452 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Hoetzer, B. L. Stauffer, J. J. Greiner, Y. Casas, D. T. Smith, and C. A. DeSouza Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E90 - E95. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Hafer-Macko, F. M. Ivey, K. A. Gyure, J. D. Sorkin, and R. F. Macko Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature Diabetes, June 1, 2002; 51(6): 1957 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lavallee, V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco Association Between Influenza Vaccination and Reduced Risk of Brain Infarction Stroke, February 1, 2002; 33(2): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lynch, K. B. Nelson, C. J. Curry, and J. K. Grether Cerebrovascular Disorders in Children With the Factor V Leiden Mutation J Child Neurol, October 1, 2001; 16(10): 735 - 744. [Abstract] [PDF] |
||||
![]() |
T. A. Kent, V. M. Soukup, and R. H. Fabian Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse Stroke, October 1, 2001; 32(10): 2318 - 2327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shibata, S. R. Kumar, A. Amar, J. A. Fernandez, F. Hofman, J. H. Griffin, and B. V. Zlokovic Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke Circulation, April 3, 2001; 103(13): 1799 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Feigin, C. S. Anderson, N. E. Anderson, J. B. Broad, M. J. Pledger, and R. Bonita Is There a Temporal Pattern in the Occurrence of Subarachnoid Hemorrhage in the Southern Hemisphere? : Pooled Data From 3 Large, Population-Based Incidence Studies in Australasia, 1981 to 1997 Stroke, March 1, 2001; 32(3): 613 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Tran, J. Correale, S. S. Schreiber, M. Fisher, and P. H. Chan Transforming Growth Factor-{beta} Mediates Astrocyte-Specific Regulation of Brain Endothelial Anticoagulant Factors • Editorial Comment Stroke, August 1, 1999; 30(8): 1671 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Kupferwasser, G. Hafner, S. Mohr-Kahaly, R. Erbel, J.u. Meyer, and H. Darius The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1365 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Macko, L. A. Killewich, J. A. Fernandez, D. K. Cox, A. Gruber, and J. H. Griffin Brain-Specific Protein C Activation During Carotid Artery Occlusion in Humans Stroke, March 1, 1999; 30(3): 542 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. DeSouza, P. P. Jones, and D. R. Seals Physical Activity Status and Adverse Age-Related Differences in Coagulation and Fibrinolytic Factors in Women Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 362 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, N. D. Tran, M. Kittaka, M. J. Fisher, S. S. Schreiber, and B. V. Zlokovic Thrombomodulin Expression in Bovine Brain Capillaries : Anticoagulant Function of the Blood-Brain Barrier, Regional Differences, and Regulatory Mechanisms Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3139 - 3146. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |